Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity

Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity / Luppi, Mario; Forghieri, Fabio; Potenza, Leonardo. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 71:12(2020), pp. 3265-3266. [10.1093/cid/ciaa323]